Gennova gets DCGI nod for Phase 2, 3 trials of its mRNA COVID vaccine ruchika25 Aug 2021 6:58 AM GMTNew Delhi: India's first mRNA-based Covid-19 vaccine candidate HGCO19 by Gennova Biopharmaceuticals Ltd has been granted approval for phase 2/3 clinica...
Gennova begins enrolment for Phase human clinical trials of HGCO19 vaccine candidate ruchika13 April 2021 12:08 PM GMTNew Delhi: Gennova has initiated the enrolment of volunteers for Phase 1/2 clinical trials for its mRNA vaccine candidate HGCO19, the Department of Bio...
Gennova Biopharma wins DCGI conditional nod for human clinical trial of Covid-19 vaccine ruchika11 Dec 2020 1:19 PM GMTThe recommendations of the Subject Expert Committee (SEC) on Covid19, which deliberated upon the proposal submitted by the firm for grant of...
Govt panel meets COVID vaccine makers including Serum Institute, Zydus Cadila, others ruchika18 Aug 2020 7:30 AM GMTNew Delhi: The national expert group on vaccine administration for Covid-19 met representatives of leading domestic manufactures, including Serum Insti...
